Current Alzheimer Research

Papers
(The TQCC of Current Alzheimer Research is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
CREB: A Multifaceted Target for Alzheimer’s Disease53
The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease30
Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer’s Disease Patients30
Accelerated Epigenetic Aging in Peripheral Blood does not Predict Dementia Risk24
Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer’s Disease22
Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats21
Diagnosis of Mild Cognitive Impairment Using Cognitive Tasks: A Functional Near-Infrared Spectroscopy Study20
Research Progress on circRNA in Nervous System Diseases19
Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer’s Disease18
An Effective Brain Imaging Biomarker for AD and aMCI: ALFF in Slow-5 Frequency Band18
Current Challenges and Limitations in the Studies of Intrinsically Disordered Proteins in Neurodegenerative Diseases by Computer Simulations18
Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia17
Alterations in Mitochondrial Dynamic-related Genes in the Peripheral Blood of Alzheimer’s Disease Patients16
Curcumin Prevents Neuroinflammation by Inducing Microglia to Transform into the M2-phenotype via CaMKKβ-dependent Activation of the AMP-Activated Protein Kinase Signal Pathway15
Low Intensity Electromagnetic Fields Act via Voltage-Gated Calcium Channel (VGCC) Activation to Cause Very Early Onset Alzheimer’s Disease: 18 Distinct Types of Evidence15
Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia15
Investigation of Low Dose Cabazitaxel Potential as Microtubule Stabilizer in Experimental Model of Alzheimer's Disease: Restoring Neuronal Cytoskeleton15
Weight Loss and the Risk of Dementia: A Meta-analysis of Cohort Studies15
Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-1915
Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-analysis15
The Relationship of Anxiety with Alzheimer’s Disease: A Narrative Review14
Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study14
Effects of Spices (Saffron, Rosemary, Cinnamon, Turmeric and Ginger) in Alzheimer's Disease13
Microglia and its Genetics in Alzheimer's Disease13
Targeting Pathological Amyloid Aggregates with Conformation-Sensitive Antibodies13
Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction13
Volumetric MRI Demonstrates Atrophy of the Olfactory Cortex in AD13
Non-steroidal Anti-inflammatory Drugs as Candidates for the Prevention or Treatment of Alzheimer’s Disease: Do they Still Have a Role?12
The Alzheimer’s Disease Amyloid Precursor Protein and its Neuritogenic Actions12
Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population11
Inflammation in Alzheimer’s Disease11
Amyloid-beta Induced Neurotoxicity Impairs Cognition and Adult Hippocampal Neurogenesis in a Mouse Model for Alzheimer’s Disease11
Robust Discovery of Mild Cognitive Impairment Subtypes and Their Risk of Alzheimer's Disease Conversion Using Unsupervised Machine Learning and Gaussian Mixture Modeling11
The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer’s Dementia Using the NACC Database11
Alzheimer’s Disease and its Related Dementia Types: A Review on Their Management Via Nanotechnology Based Therapeutic Strategies11
Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer’s Disease Patients: How to Measure and Use It10
Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer’s and Parkinson’s Disease10
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease10
Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia10
Metabolic Syndrome, Alzheimer’s Disease, and Covid 19: A Possible Correlation10
Electromagnetic Field in Alzheimer’s Disease: A Literature Review of Recent Preclinical and Clinical Studies9
Functional Connectivity Alterations Based on the Weighted Phase Lag Index: An Exploratory Electroencephalography Study on Alzheimer’s Disease9
Neuroprotector Effect of Daily 8-Minutes of High-Intensity Interval Training in Rat Aβ1-42 Alzheimer Disease Model9
Carotid Arterial Stiffness and Cerebral Blood Flow in Amnestic Mild Cognitive Impairment9
IL-8 and MCP-1 Impact on Tau Phosphorylation and Phosphatase Activity9
Serine Racemase Expression Differentiates Aging from Alzheimer’s Brain9
Degradation Products of Amyloid Protein: Are They The Culprits?8
A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships8
Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis8
β-Amyloid is an Immunopeptide and Alzheimer’s is an Autoimmune Disease8
Huntingtin Levels are Elevated in Hippocampal Post-Mortem Samples of Alzheimer’s Disease Brain8
RAGE Isoforms, its Ligands and their Role in Pathophysiology of Alzheimer’s Disease8
Neutrophil Granule Proteins Inhibit Amyloid Beta Aggregation and Neurotoxicity8
Retinal Changes in Transgenic Mouse Models of Alzheimer’s Disease8
Mitochondrial Dysfunction as a Causative Factor in Alzheimer’s Disease-Spectrum Disorders: Lymphocytes as a Window to the Brain8
Astrocyte Reactivity in Alzheimer’s Disease: Therapeutic Opportunities to Promote Repair8
Microglial Store-operated Calcium Signaling in Health and in Alzheimer’s Disease8
Codonopsis pilosula Polysaccharides Alleviate Aβ1-40-Induced PC12 Cells Energy Dysmetabolism via CD38/NAD+ Signaling Pathway8
Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer’s Disease Based on Three Chinese MRI Datasets7
Polymorphism Rs2421943 of the Insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer’s Disease7
Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD7
The Interaction of Dynamic Cerebral Autoregulation and Neurovascular Coupling in Cognitive Impairment7
Association of Red Blood Cell Indices with Mild Cognitive Impairment in Chinese Elderly Individuals: A Matched Case-control Study7
Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's Disease Dementia7
High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice7
Identification of Somatic Mutations in Dementia-related Genes in Cancer Patients7
Gastrointestinal Changes and Alzheimer's Disease7
Clinical Phenotype and Mutation Spectrum of Alzheimer’s Disease with Causative Genetic Mutation in a Chinese Cohort7
Exendin-4 Improves Cognitive Function of Diabetic Mice via Increasing Brain Insulin Synthesis7
Dihydroartemisinin Ameliorates Decreased Neuroplasticity-Associated Proteins and Excessive Neuronal Apoptosis in APP/PS1 Mice7
A Novel Probiotic Formula, BIOCG, Protects Against Alzheimer’s-Related Cognitive Deficits via Regulation of Dendritic Spine Dynamics6
Tele-Mindfulness for Dementia's Family Caregivers: A Randomized Trial with a Usual Care Control Group6
Oxidative Damage of Proteins Precedes Loss of Cholinergic Phenotype in the Septal Neurons of Olfactory Bulbectomized Mice6
A Comprehensive Investigation of Molecular Signatures and Pathways Linking Alzheimer’s Disease and Epilepsy via Bioinformatic Approaches6
Digital Intervention for the Management of Alzheimer’s Disease6
Automatic Assessment of Cognitive Tests for Differentiating Mild Cognitive Impairment: A Proof of Concept Study of the Digit Span Task6
Sixteen Weeks of Aerobic Exercise does not Alter Resting-state Connectivity of the Precuneus in Patients with Alzheimer’s Disease6
Enhanced Anti-Amyloid Effect of Combined Leptin and Pioglitazone in APP/PS1 Transgenic Mice6
Risk Factors for Alzheimer’s Disease: An Epidemiological Study6
Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease6
Parkinson’s Symptoms and Caregiver Affiliate Stigma: A Multinational Study6
Diversity and Regulation of Astrocyte Neurotoxicity in Alzheimer's Disease6
Impairment of Store-operated Calcium Entry: Implications in Alzheimer’s Neurodegeneration6
Association Serum S100B Protein in Alzheimer’s Disease: A Case Control Study from South India6
Development and Validation of a Model to Identify Alzheimer’s Disease and Related Syndromes in Administrative Data6
Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer’s Disease: A 6-Month Retrospective Follow-Up Study6
Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer’s Disease and Amnestic Mild Cognitive Impairment6
Rectifying Attenuated Store-Operated Calcium Entry as a Therapeutic Approach for Alzheimer’s Disease6
Salivary Aβ Secretion and Altered Oral Microbiome in Mouse Models of AD6
Caffeine Improve Memory and Cognition via Modulating Neural Progenitor Cell Survival and Decreasing Oxidative Stress in Alzheimer's Rat Model6
Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study6
Risk Assessment During Longitudinal Progression of Cognition in Older Adults: A Community-based Bayesian Networks Model6
Functional Roles of Neuronal Nitric Oxide Synthase in Neurodegenerative Diseases and Mood Disorders5
APP/PS1 Gene-Environment Noise Interaction Aggravates AD-like Neuropathology in Hippocampus Via Activation of the VDAC1 Positive Feedback Loop5
BACE-1 Inhibitors Targeting Alzheimer's Disease5
The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship5
Physical Work and Exercise Reduce the Risk of Cognitive Impairment in Older Adults: A Population-based Longitudinal Study5
From Infection to Inoculation: Expanding the Microbial Hypothesis of Alzheimer’s Disease5
Blood Neurofilament Light Chain in Different Types of Dementia5
Inflammatory Biomarkers in AD: Implications for Diagnosis5
Poststroke Cognitive Impairment: A Longitudinal Follow-Up and Pre/Poststroke Mini-Mental State Examination Comparison5
The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions5
Directed Network Defects in Alzheimer's Disease Using Granger Causality and Graph Theory5
Connectivity and Patterns of Regional Cerebral Blood Flow, Cerebral Glucose Uptake, and Aβ-Amyloid Deposition in Alzheimer's Disease (Early and Late-Onset) Compared to Normal Ageing5
Random-Forest-Algorithm-Based Applications of the Basic Characteristics and Serum and Imaging Biomarkers to Diagnose Mild Cognitive Impairment5
Effects of Supplementation with Probiotics in Experimental Models of Alzheimer's Disease: A Systematic Review of Animal Experiments5
Elucidating the Risk Factors for Progression from Amyloid-Negative Amnestic Mild Cognitive Impairment to Dementia5
Synthesis, Molecular Docking, and Biological Evaluation of Benzimidazole Derivatives as Selective Butyrylcholinesterase Inhibitors5
Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant5
Modifiable Risk Factors for Dementia: The Role of Gut Microbiota5
Pesticide Exposure and Alzheimer’s Disease: A Case-control Study5
Vascular Lesions and Brain Atrophy in Alzheimer’s, Vascular and Mixed Dementia: An Optimized 3T MRI Protocol Reveals Distinctive Radiological Profiles5
Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain5
Acting Before; A Combined Strategy to Counteract the Onset and Progression of Dementia5
A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer’s Disease in Subjects with Mild Cognitive Impairment5
A Timeline of Ca2+/cAMP Signalling: From Basic Research to Potential Therapeutics for Dementia5
0.032545804977417